Actively Recruiting
Psychological Treatment for Paraphilic Disorders
Led by Region Stockholm · Updated on 2026-03-03
14
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized study is to learn if a psychological intervention can treat help-seeking patients with paraphilic disorders. The main questions it aims to answer are: 1. Is psychological therapy helpful for the reduction of problematic sexual behaviors among patients with paraphilic disorders? 2. Is psychological helpful for the reduction of psychiatric symptoms and risk factors for sexual violence and improving quality of life among patients with paraphilic disorders? 3. How do patients with paraphilic disorders describe pathways to care (e.g. perceived obstacles to seeking care) and how do they experience the treatment? The treatment addresses specific sexual problems. It also addresses mental symptoms (e.g. depression and anxiety). A psychologist provides the treatment face to face (on site or video). The aim is to finish the treatment within 12 weeks. The patient will report symptoms on a daily basis. The patient will also be interviewed after completion of treatment. The investigator will pose questions such as "Was there anything that was experienced as particularly helpful in the treatment?", "Was there anything that was not helpful?". The investigator will also ask about treatment seeking behavior with questions such as "What kinds of resources would be helpful if they were available?"
CONDITIONS
Official Title
Psychological Treatment for Paraphilic Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants included in the study Paraphilic Disorders and Other Conditions With Risk for Sexual Violence: a Case-control Study
- Deemed to benefit from CBT
- Signed informed consent form for participation in the CBT treatment
You will not qualify if you...
- Mental condition that could negatively influence the patient's health or the study, such as substance use syndrome or other ongoing psychotherapeutic treatment
- Started or changed medication or dosage in the past 3 months for antidepressants, ADHD medication, cortisone, testosterone, naltrexone, testosterone blockers, or dopamine precursors (small adjustments may be acceptable if assessed by study psychiatrist)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ANOVA, Karolinska university hospital
Stockholm, Stockholm County, Sweden, 171 76
Actively Recruiting
Research Team
J
josephine savard, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here